title: Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.
abstract: Several genome-wide association studies on breast cancer (BC) have reported similar findings of a new susceptibility locus, 5p12. After that, a number of studies reported that the rs10941679, rs4415084, and rs981782 polymorphism in chromosome 5p12 has been implicated in BC risk. However, the studies have yielded contradictory results. To derive a more precise estimation of the relationship, a meta-analysis of 131,983 BC cases and 200,314 controls from 24 published case-control studies was performed. Overall, significantly elevated BC risk was associated with rs10941679, rs4415084, and rs981782 risk allele when all studies were pooled into the meta-analysis. In the subgroup analysis by ethnicity, significantly increased risks were found for the rs10941679 and rs4415084 polymorphism among Caucasians and East Asians, while no significant associations were observed for the two polymorphisms in African and other ethnic populations. For 5p12-rs981782, significant associations were only detected among Caucasians. In addition, we found that rs10941679 and rs4415084 on 5p12 confer risk, exclusively for estrogen receptor (ER)-positive tumors with per-allele OR of 1.16 (95% CI: 1.11-1.21; P<10(-5)) and of 1.14 (95% CI: 1.09-1.19; P<10(-5)) respectively. Ethnicity was identified as a potential source of between-study heterogeneity. In conclusion, this meta-analysis demonstrated that common variations are a risk factor associated with increased BC susceptibility, but these associations vary in different ethnic populations.
authors: Department of Breast Surgery, Huangpu Central Hospital of Shanghai, Shanghai, People's Republic of China.
authors: Yanmin
authors: Y
authors: Yu
authors: Zenggan
authors: Z
authors: Chen
authors: Hong
authors: H
authors: Wang
authors: Yan
authors: Y
authors: Zhang
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism; D016022:Case-Control Studies; D002895:Chromosomes, Human, Pair 5; D005260:Female; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D011960:Receptors, Estrogen / Q000378:metabolism; D012307:Risk Factors
chemical_list: D011960:Receptors, Estrogen
references: Breast Cancer Res Treat. 2012 Nov;136(1):209-20
references: 22965832
references: JAMA. 2006 Mar 22;295(12):1379-88
references: 16551709
references: Nat Genet. 2002 May;31(1):33-6
references: 11984562
references: Oncogene. 2006 Sep 25;25(43):5898-905
references: 16998504
references: Nat Genet. 2007 Jul;39(7):870-4
references: 17529973
references: BMJ. 2000 Sep 9;321(7261):624-8
references: 10977847
references: Hum Mol Genet. 2013 Jun 15;22(12):2539-50
references: 23535825
references: Breast Cancer Res Treat. 2011 Jan;125(2):479-87
references: 20549339
references: Nat Med. 2001 May;7(5):552-6
references: 11329055
references: Control Clin Trials. 1986 Sep;7(3):177-88
references: 3802833
references: J Hum Genet. 2012 Oct;57(10):638-41
references: 22832384
references: Breast Cancer Res Treat. 2011 Apr;126(3):717-27
references: 20872241
references: Nat Genet. 2013 Apr;45(4):353-61, 361e1-2
references: 23535729
references: Breast Cancer Res Treat. 2012 Apr;132(2):711-21
references: 22160591
references: Biometrics. 1994 Dec;50(4):1088-101
references: 7786990
references: J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63
references: 21791674
references: Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2222-31
references: 21795498
references: Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9362-7
references: 19474294
references: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2761-4
references: 19789366
references: Nat Genet. 2003 Mar;33 Suppl:238-44
references: 12610533
references: Nat Genet. 2008 Jun;40(6):703-6
references: 18438407
references: Br J Cancer. 2012 Jan 17;106(2):389-96
references: 22045194
references: Carcinogenesis. 2010 Aug;31(8):1417-23
references: 20554749
references: Breast Cancer Res Treat. 2012 Dec;136(3):847-57
references: 23117855
references: Lancet. 2002 Jul 20;360(9328):187-95
references: 12133652
references: Nature. 2007 Jun 28;447(7148):1087-93
references: 17529967
references: Breast Cancer Res Treat. 2010 Sep;123(2):525-30
references: 20140701
references: BMJ. 1997 Sep 13;315(7109):629-34
references: 9310563
references: J Natl Cancer Inst. 2011 Mar 2;103(5):425-35
references: 21263130
references: Breast Cancer Res. 2012 Mar 27;14(2):R56
references: 22452962
references: Radiat Res. 2010 Feb;173(2):214-24
references: 20095854
references: N Engl J Med. 2008 Jan 17;358(3):213-6
references: 18199859
references: Nat Genet. 2009 May;41(5):579-84
references: 19330030
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Nat Genet. 2009 May;41(5):585-90
references: 19330027
references: Breast Cancer Res. 2012 Jan 23;14(1):R17
references: 22269215
references: Cancer Res. 2010 Dec 1;70(23):9742-54
references: 21118973
references: Nat Genet. 2007 Jul;39(7):865-9
references: 17529974
references: Nat Rev Genet. 2006 Dec;7(12):958-65
references: 17139327
references: Carcinogenesis. 2012 Apr;33(4):835-40
references: 22357627
references: Breast Cancer Res Treat. 2013 Jan;137(2):511-22
references: 23184080
references: Stat Med. 1999 Oct 30;18(20):2693-708
references: 10521860
references: Hum Mol Genet. 2010 Jul 15;19(14):2886-97
references: 20418484
references: JAMA. 2010 Jul 28;304(4):426-34
references: 20664043
references: Br J Cancer. 2002 Jan 7;86(1):76-83
references: 11857015
references: J Natl Cancer Inst. 2010 Jul 7;102(13):972-81
references: 20484103
references: Breast Cancer Res. 2011;13(6):R114
references: 22087758
references: Breast Cancer Res Treat. 2009 Sep;117(1):151-9
references: 19005751
references: Nat Genet. 2010 Jun;42(6):504-7
references: 20453838